Literature DB >> 19238516

Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

Yildiz Oner-Iyidogan1, Pernur Oner, Hikmet Kocak, Figen Gurdol, Seldag Bekpinar, Yesim Unlucerci, Yasar Caliskan, Pinar Cetinalp-Demircan, Taner Kocak, Aydin Turkmen.   

Abstract

The aim of this study was to investigate the pro-oxidant and proinflammatory biomarkers and their relationship with dimethylarginines (DMAs) in patients at various stages of chronic kidney disease (CKD). We studied 114 CKD patients, 36 were hemodialyzed, 41 peritoneal dialyzed and 37 nondialyzed (early stage) CKD patients. The control group consisted of 31 healthy subjects. Plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), L-arginine, nitric oxide (NO) and proinflammatory cytokines (TNF-alpha and IL-6) were determined, and their relationships with the degree of disease were evaluated. Both DMAs were at high levels in all CKD patients, whereas arginine concentrations were low in patients undergoing dialysis. Elevated TNF-alpha and IL-6 in CKD patients were indicative of ongoing chronic inflammatory state. A significant positive correlation between SDMA and creatinine suggests that plasma SDMA level may be an index for renal function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238516     DOI: 10.1007/s10238-009-0035-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  31 in total

1.  Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.

Authors:  Jan T Kielstein; Shelley R Salpeter; Stefanie M Bode-Boeger; John P Cooke; Danilo Fliser
Journal:  Nephrol Dial Transplant       Date:  2006-06-09       Impact factor: 5.992

Review 2.  Appetite in CAPD patients.

Authors:  J Bergström
Journal:  Perit Dial Int       Date:  1996       Impact factor: 1.756

Review 3.  Protein catabolism in maintenance haemodialysis: the influence of the dialysis membrane.

Authors:  A Gutierrez
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

4.  Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure.

Authors:  R J MacAllister; M H Rambausek; P Vallance; D Williams; K H Hoffmann; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

5.  Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment.

Authors:  T Nguyen-Khoa; Z A Massy; J P De Bandt ; M Kebede; L Salama; G Lambrey; V Witko-Sarsat; T B Drüeke; B Lacour; M Thévenin
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

Review 6.  Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure.

Authors:  A C Mendes Ribeiro; T M Brunini; J C Ellory; G E Mann
Journal:  Cardiovasc Res       Date:  2001-03       Impact factor: 10.787

Review 7.  Nitric oxide, malnutrition and chronic renal failure.

Authors:  Tatiana M C Brunini; Monique B Moss; Mariana A S Siqueira; Sérgio F F Santos; Jocemir R Lugon; Antônio C Mendes-Ribeiro
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-04

8.  Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.

Authors:  B Marescau; G Nagels; I Possemiers; M E De Broe; I Becaus; J M Billiouw; W Lornoy; P P De Deyn
Journal:  Metabolism       Date:  1997-09       Impact factor: 8.694

9.  Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.

Authors:  David E L Wilcken; Jun Wang; Ah Siew Sim; Kathryn Green; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 10.  Protein damage and inflammation in uraemia and dialysis patients.

Authors:  Francesco Galli
Journal:  Nephrol Dial Transplant       Date:  2007-07       Impact factor: 5.992

View more
  6 in total

1.  Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.

Authors:  Eva Schepers; Daniela V Barreto; Sophie Liabeuf; Griet Glorieux; Sunny Eloot; Fellype C Barreto; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

Review 2.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

3.  Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy.

Authors:  Dharmeshkumar Parmar; Nivedita Bhattacharya; Shanthini Kannan; Sangeetha Vadivel; Gautam Kumar Pandey; Avinash Ghanate; Nagarjuna Chary Ragi; Paramasivam Prabu; Thyparambil Aravindakshan Pramodkumar; Nagaraj Manickam; Viswanathan Mohan; Prabhakar Sripadi; Gokulakrishnan Kuppan; Venkateswarlu Panchagnula
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

4.  Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis.

Authors:  André Nanny Vieira Le Sueur; Silvano Salgueiro Geraldes; Alessandra Melchert; Regina Kiomi Takahira; Michael Coyne; Rachel Murphy; Donald Szlosek; Priscylla Tatiana Chalfun Guimarães-Okamoto
Journal:  J Vet Intern Med       Date:  2019-09-12       Impact factor: 3.333

Review 5.  Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

Authors:  Shufen Chen; Na Li; Milani Deb-Chatterji; Qiang Dong; Jan T Kielstein; Karin Weissenborn; Hans Worthmann
Journal:  Int J Mol Sci       Date:  2012-11-28       Impact factor: 5.923

Review 6.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.